Abiogen acquires EffRx to fortify bone disease portfolio
Pharmaceutical Technology
MAY 30, 2023
The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals on May 29. Altamedics specialises in pharmaceutical distribution in hospital settings. Alkindi is one of EffRx’s three marketed drugs.
Let's personalize your content